NO20054032D0 - Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene. - Google Patents
Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene.Info
- Publication number
- NO20054032D0 NO20054032D0 NO20054032A NO20054032A NO20054032D0 NO 20054032 D0 NO20054032 D0 NO 20054032D0 NO 20054032 A NO20054032 A NO 20054032A NO 20054032 A NO20054032 A NO 20054032A NO 20054032 D0 NO20054032 D0 NO 20054032D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- intermediates
- processes
- glycolipid derivatives
- glycolipid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/04—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Crystallography & Structural Chemistry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003037397 | 2003-02-14 | ||
| PCT/JP2004/001566 WO2004072091A1 (ja) | 2003-02-14 | 2004-02-13 | 糖脂質誘導体及びその製造法並びにそれらの合成中間体及びその製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054032D0 true NO20054032D0 (no) | 2005-08-30 |
| NO20054032L NO20054032L (no) | 2005-11-01 |
Family
ID=32866358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054032A NO20054032L (no) | 2003-02-14 | 2005-08-30 | Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7732583B2 (no) |
| EP (2) | EP1619199B1 (no) |
| JP (2) | JP4742220B2 (no) |
| KR (1) | KR20050105215A (no) |
| CN (2) | CN101165047B (no) |
| AU (1) | AU2004210784A1 (no) |
| BR (1) | BRPI0407501A (no) |
| CA (1) | CA2515396A1 (no) |
| ES (2) | ES2450043T3 (no) |
| HU (1) | HUE037560T2 (no) |
| NO (1) | NO20054032L (no) |
| WO (1) | WO2004072091A1 (no) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9809654B2 (en) | 2002-09-27 | 2017-11-07 | Vaccinex, Inc. | Targeted CD1d molecules |
| WO2006026389A2 (en) * | 2004-08-27 | 2006-03-09 | Albert Einstein College Of Medicine Of Yeshiva University | Ceramide derivatives as modulators of immunity and autoimmunity |
| JP5090928B2 (ja) * | 2004-12-28 | 2012-12-05 | ザ ロックフェラー ユニバーシティ | Ｎｋｔ細胞に対する抗原としての糖脂質及びその類似体 |
| US7923013B2 (en) * | 2004-12-28 | 2011-04-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NKT cells |
| KR20080021761A (ko) * | 2005-07-01 | 2008-03-07 | 국립 정신.신경센터 총장이 대표하는 일본국 | 당지질 유도체 및 이것을 유효 성분으로 하는 치료제 |
| WO2008047174A1 (en) * | 2006-10-18 | 2008-04-24 | Centre National De La Recherche Scientifique | Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
| CA2678618C (en) * | 2007-02-21 | 2019-03-12 | Vaccinex, Inc. | Modulation of nkt cell activity with antigen-loaded cd1d molecules |
| DK2385980T3 (en) | 2009-01-08 | 2018-07-30 | Albert Einstein College Medicine Inc | BACTERIA VACCINES WITH CELL-WALL-ASSOCIATED CERAMIDE-LIKE GLYCOLIPIDS AND APPLICATIONS THEREOF |
| CN101775051B (zh) * | 2010-01-07 | 2013-03-27 | 北京大学 | 一种区域选择性脱除糖o-苄基保护基的方法 |
| US10632740B2 (en) | 2010-04-23 | 2020-04-28 | Landa Corporation Ltd. | Digital printing process |
| US9381736B2 (en) | 2012-03-05 | 2016-07-05 | Landa Corporation Ltd. | Digital printing process |
| US10434761B2 (en) | 2012-03-05 | 2019-10-08 | Landa Corporation Ltd. | Digital printing process |
| US10642198B2 (en) | 2012-03-05 | 2020-05-05 | Landa Corporation Ltd. | Intermediate transfer members for use with indirect printing systems and protonatable intermediate transfer members for use with indirect printing systems |
| US9643400B2 (en) | 2012-03-05 | 2017-05-09 | Landa Corporation Ltd. | Treatment of release layer |
| US9643403B2 (en) | 2012-03-05 | 2017-05-09 | Landa Corporation Ltd. | Printing system |
| DE202013012736U1 (de) | 2012-03-05 | 2018-12-20 | Landa Corporation Ltd. | Tintenfilmkonstruktionen |
| AU2013229142B2 (en) | 2012-03-05 | 2017-02-02 | Landa Corporation Ltd. | Ink film constructions |
| WO2015036960A1 (en) | 2013-09-11 | 2015-03-19 | Landa Corporation Ltd. | Release layer treatment formulations |
| US10190012B2 (en) | 2012-03-05 | 2019-01-29 | Landa Corporation Ltd. | Treatment of release layer and inkjet ink formulations |
| US9902147B2 (en) | 2012-03-05 | 2018-02-27 | Landa Corporation Ltd. | Digital printing system |
| US9498946B2 (en) | 2012-03-05 | 2016-11-22 | Landa Corporation Ltd. | Apparatus and method for control or monitoring of a printing system |
| CN104284850B (zh) | 2012-03-15 | 2018-09-11 | 兰达公司 | 打印系统的环形柔性皮带 |
| US9371352B2 (en) | 2013-02-08 | 2016-06-21 | Vaccinex, Inc. | Modified glycolipids and methods of making and using the same |
| EP2953957B1 (en) | 2013-02-08 | 2019-04-10 | Vaccinex, Inc. | Modified glycolipids and methods of making and using the same |
| GB201401173D0 (en) | 2013-09-11 | 2014-03-12 | Landa Corp Ltd | Ink formulations and film constructions thereof |
| GB2536489B (en) | 2015-03-20 | 2018-08-29 | Landa Corporation Ltd | Indirect printing system |
| GB2537813A (en) | 2015-04-14 | 2016-11-02 | Landa Corp Ltd | Apparatus for threading an intermediate transfer member of a printing system |
| GB201609463D0 (en) | 2016-05-30 | 2016-07-13 | Landa Labs 2012 Ltd | Method of manufacturing a multi-layer article |
| DE112017002714T5 (de) | 2016-05-30 | 2019-02-28 | Landa Corporation Ltd. | Digitales Druckverfahren |
| DE112018004530T5 (de) | 2017-10-19 | 2020-07-09 | Landa Corporation Ltd. | Endloses flexibles band für ein drucksystem |
| JP7225230B2 (ja) | 2017-11-19 | 2023-02-20 | ランダ コーポレイション リミテッド | デジタル印刷システム |
| US11511536B2 (en) | 2017-11-27 | 2022-11-29 | Landa Corporation Ltd. | Calibration of runout error in a digital printing system |
| US11707943B2 (en) | 2017-12-06 | 2023-07-25 | Landa Corporation Ltd. | Method and apparatus for digital printing |
| US11679615B2 (en) | 2017-12-07 | 2023-06-20 | Landa Corporation Ltd. | Digital printing process and method |
| WO2020003088A1 (en) | 2018-06-26 | 2020-01-02 | Landa Corporation Ltd. | An intermediate transfer member for a digital printing system |
| US10994528B1 (en) | 2018-08-02 | 2021-05-04 | Landa Corporation Ltd. | Digital printing system with flexible intermediate transfer member |
| WO2020035766A1 (en) | 2018-08-13 | 2020-02-20 | Landa Corporation Ltd. | Correcting distortions in digital printing by implanting dummy pixels in a digital image |
| US11318734B2 (en) | 2018-10-08 | 2022-05-03 | Landa Corporation Ltd. | Friction reduction means for printing systems and method |
| JP7462648B2 (ja) | 2018-12-24 | 2024-04-05 | ランダ コーポレイション リミテッド | デジタル印刷システム |
| CN114746813A (zh) | 2019-11-25 | 2022-07-12 | 兰达公司 | 在数字印刷中使用红外辐射来干燥油墨 |
| US11321028B2 (en) | 2019-12-11 | 2022-05-03 | Landa Corporation Ltd. | Correcting registration errors in digital printing |
| JPWO2022102557A1 (no) * | 2020-11-12 | 2022-05-19 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6072960A (ja) * | 1983-09-30 | 1985-04-25 | Sumitomo Chem Co Ltd | モノアゾ化合物およびそれを用いて染色または捺染する方法 |
| JPH0559081A (ja) * | 1991-08-29 | 1993-03-09 | Kirin Brewery Co Ltd | 新規スフインゴ糖脂質、その製造法および使用 |
| US5936076A (en) * | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
| US5849716A (en) * | 1992-10-22 | 1998-12-15 | Kirin Beer Kabushiki Kaisha | Sphingoglycolipids, their preparation, and therapeutic methods of use |
| JP2002226377A (ja) | 1996-10-14 | 2002-08-14 | Kirin Brewery Co Ltd | 配糖体含有末梢血幹細胞増加剤 |
| WO1998044928A1 (en) * | 1997-04-10 | 1998-10-15 | Kirin Beer Kabushiki Kaisha | NKT CELL ACTIVATORS CONTAINING α-GLYCOSYLCERAMIDES |
| KR100880063B1 (ko) * | 2001-08-16 | 2009-01-22 | 아스비오파마 가부시키가이샤 | 신규한 당지질 및 이것을 유효성분으로 하는 자기면역질환 치료약 |
-
2004
- 2004-02-13 HU HUE11160814A patent/HUE037560T2/hu unknown
- 2004-02-13 KR KR1020057014984A patent/KR20050105215A/ko not_active Application Discontinuation
- 2004-02-13 CA CA002515396A patent/CA2515396A1/en not_active Abandoned
- 2004-02-13 AU AU2004210784A patent/AU2004210784A1/en not_active Abandoned
- 2004-02-13 WO PCT/JP2004/001566 patent/WO2004072091A1/ja active Application Filing
- 2004-02-13 EP EP04710993.9A patent/EP1619199B1/en not_active Expired - Lifetime
- 2004-02-13 EP EP11160814.7A patent/EP2343306B1/en not_active Expired - Lifetime
- 2004-02-13 CN CN2007101544258A patent/CN101165047B/zh not_active Expired - Lifetime
- 2004-02-13 BR BRPI0407501-3A patent/BRPI0407501A/pt not_active IP Right Cessation
- 2004-02-13 US US10/545,421 patent/US7732583B2/en active Active
- 2004-02-13 CN CNB200480004216XA patent/CN100537585C/zh not_active Expired - Lifetime
- 2004-02-13 JP JP2005505007A patent/JP4742220B2/ja not_active Expired - Lifetime
- 2004-02-13 ES ES04710993.9T patent/ES2450043T3/es not_active Expired - Lifetime
- 2004-02-13 ES ES11160814.7T patent/ES2676345T3/es not_active Expired - Lifetime
-
2005
- 2005-08-30 NO NO20054032A patent/NO20054032L/no not_active Application Discontinuation
-
2010
- 2010-04-15 US US12/760,793 patent/US8034908B2/en not_active Expired - Fee Related
- 2010-10-12 JP JP2010229896A patent/JP5246448B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2450043T3 (es) | 2014-03-21 |
| AU2004210784A1 (en) | 2004-08-26 |
| CN100537585C (zh) | 2009-09-09 |
| CN1768072A (zh) | 2006-05-03 |
| EP2343306A1 (en) | 2011-07-13 |
| JP4742220B2 (ja) | 2011-08-10 |
| WO2004072091B1 (ja) | 2004-11-11 |
| EP2343306B1 (en) | 2018-04-04 |
| CN101165047A (zh) | 2008-04-23 |
| US20060074235A1 (en) | 2006-04-06 |
| JPWO2004072091A1 (ja) | 2006-06-01 |
| ES2676345T3 (es) | 2018-07-18 |
| CN101165047B (zh) | 2010-10-20 |
| EP1619199A1 (en) | 2006-01-25 |
| CA2515396A1 (en) | 2004-08-26 |
| US7732583B2 (en) | 2010-06-08 |
| HUE037560T2 (hu) | 2018-09-28 |
| WO2004072091A1 (ja) | 2004-08-26 |
| BRPI0407501A (pt) | 2006-02-14 |
| US8034908B2 (en) | 2011-10-11 |
| US20100210828A1 (en) | 2010-08-19 |
| KR20050105215A (ko) | 2005-11-03 |
| EP1619199A4 (en) | 2009-12-16 |
| NO20054032L (no) | 2005-11-01 |
| JP2011063593A (ja) | 2011-03-31 |
| JP5246448B2 (ja) | 2013-07-24 |
| EP1619199B1 (en) | 2013-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054032D0 (no) | Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene. | |
| NO20034930L (no) | Substituerte cykloheksan-1,4-diaminderivater | |
| IS7755A (is) | Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín | |
| MA28576B1 (fr) | Procede de preparation de derives n-piperidino-1,5-diphenylpyrazole-3-carboxamide. | |
| NL1030010A1 (nl) | 4-Amino-gesubstitueerde-2-gesubstitueerde-1,2,3,4- tetrahydrochinolineverbindingen. | |
| BR0317779B1 (pt) | composiÇço de revestimento. | |
| NO20041200L (no) | Fremgangsmate for fremstilling av citalopram. | |
| DE602004007387D1 (de) | 5-substituierte chinazolinonderivate | |
| ITTO20030850A1 (it) | Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro. | |
| NO20044332L (no) | Forbedret fremgangsmate for fremstilling av nevirapine | |
| ITMI20030346A1 (it) | Procedimento per la produzione di mesitilene. | |
| NO20052593D0 (no) | Kontinuerlig fremgangsmate for fremstilling av fruktopyranose sulfamat derivater. | |
| FR2862964B1 (fr) | Derives de la diphenylamine. | |
| ITTO20030264A1 (it) | Anello. | |
| NO20020308D0 (no) | Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten | |
| ITMI20030352A1 (it) | Metodo per la sintesi di metiltriossorenio. | |
| IT1338456B1 (it) | Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato | |
| CL2004001156A1 (es) | Procedimiento de preparacion de compuestos heterociclicos. | |
| PT1490363E (pt) | Processos de preparacao da 2-(7-cloro-1,8-naftiridina-2-il)-3-(5-metil-2-oxo-hexil)-1-isoindolinona | |
| ITRM20030053A1 (it) | Associazione di farmaci antidiabetici. | |
| ITMI20032069A1 (it) | Procedimento per la preparazione di derivati benzilmidazolici. | |
| ATE348799T1 (de) | Substituierte cyclohexanderivate | |
| ITTO20020465A0 (it) | Procedimento per la preparazione di doxofillina. | |
| ITBO20030202A1 (it) | Salvietta termica. | |
| ITMI20030462A1 (it) | Procedimento per la preparazione di citalopram bromidrato altamento pura. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |